Sanofi to produce 100 million Pfizer/BioNTech vaccine doses, CEO says
- Country:
- France
French pharma giant Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the end of the year, CEO Paul Hudson told Le Figaro newspaper in an interview published on Tuesday.
As Sanofi and its British partner GlaxoSmithKline have delayed the launch of their shot to late 2021, the French company decided to approach Pfizer "in order to be helpful as of now", Hudson said, adding that an agreement with the U.S. company had been reached.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Advertisement
ALSO READ
French foreign minister suggests sanctions on Israel to get aid into Gaza
Court finds former French mayor's climate case inadmissible
Serbia announces a possible purchase of French-made fighter jets that would mark a shift from Russia
Philippines president says trilateral summit with U.S., Japan to include South China Sea cooperation
US STOCKS-U.S. stocks inch to higher close as markets brace for CPI data, earnings